Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure

Kou-Gi Shyu, M. J. Lu, B. W. Wang, H. Y. Sun, H. Chang

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Background: Mechanical stress increases myocardial myostatin expression. However, the expression of myostatin in chronic heart failure resulting from volume-overload and after treatment with β-blockers is little known. The authors hypothesize that myostatin plays a role in the failing myocardium because of volume-overload. Materials and methods: Aorto-caval shunt was created over a 4-week period in adult Sprague-Dawley rats to induce volume-overload heart failure. Results: Heart weight and body weight ratio significantly increased after shunting. The left ventricular end-diastolic dimension also significantly increased. Treatment with carvedilol in the shunt group reversed the increase in heart weight and ventricular dimension to the baseline values. Myocardial and skeletal myostatin proteins were up-regulated in the shunt group. The mRNA of myocardial myostatin also increased in the shunt group. Treatment with carvedilol reversed both protein and mRNA of myocardial myostatin to the baseline values. Treatment with N-acetylcysteine and doxazosin partially decreased myostatin mRNA and protein expression as compared with the shunt group. Carvedilol normalized the increased immunohistochemical labelling of myocardial myostatin in the shunt group. Conclusion: Myocardial myostatin mRNA and protein expression were up-regulated in the rat model of volume-overload heart failure. Treatment with carvedilol is associated with a limitation of increased myostatin expression in the failing ventricular myocardium.

Original languageEnglish
Pages (from-to)713-719
Number of pages7
JournalEuropean Journal of Clinical Investigation
Volume36
Issue number10
DOIs
Publication statusPublished - Oct 2006

Fingerprint

Myostatin
Rats
Myocardium
Heart Failure
Messenger RNA
Proteins
Doxazosin
Weights and Measures
Venae Cavae
Mechanical Stress
Acetylcysteine
Labeling
Sprague Dawley Rats
Body Weight

Keywords

  • Beta-blocker
  • Congestive heart failure
  • Gene expression
  • Myostatin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure. / Shyu, Kou-Gi; Lu, M. J.; Wang, B. W.; Sun, H. Y.; Chang, H.

In: European Journal of Clinical Investigation, Vol. 36, No. 10, 10.2006, p. 713-719.

Research output: Contribution to journalArticle

Shyu, Kou-Gi ; Lu, M. J. ; Wang, B. W. ; Sun, H. Y. ; Chang, H. / Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure. In: European Journal of Clinical Investigation. 2006 ; Vol. 36, No. 10. pp. 713-719.
@article{bb718fdcf894406f9a6c23f85a8f0e19,
title = "Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure",
abstract = "Background: Mechanical stress increases myocardial myostatin expression. However, the expression of myostatin in chronic heart failure resulting from volume-overload and after treatment with β-blockers is little known. The authors hypothesize that myostatin plays a role in the failing myocardium because of volume-overload. Materials and methods: Aorto-caval shunt was created over a 4-week period in adult Sprague-Dawley rats to induce volume-overload heart failure. Results: Heart weight and body weight ratio significantly increased after shunting. The left ventricular end-diastolic dimension also significantly increased. Treatment with carvedilol in the shunt group reversed the increase in heart weight and ventricular dimension to the baseline values. Myocardial and skeletal myostatin proteins were up-regulated in the shunt group. The mRNA of myocardial myostatin also increased in the shunt group. Treatment with carvedilol reversed both protein and mRNA of myocardial myostatin to the baseline values. Treatment with N-acetylcysteine and doxazosin partially decreased myostatin mRNA and protein expression as compared with the shunt group. Carvedilol normalized the increased immunohistochemical labelling of myocardial myostatin in the shunt group. Conclusion: Myocardial myostatin mRNA and protein expression were up-regulated in the rat model of volume-overload heart failure. Treatment with carvedilol is associated with a limitation of increased myostatin expression in the failing ventricular myocardium.",
keywords = "Beta-blocker, Congestive heart failure, Gene expression, Myostatin",
author = "Kou-Gi Shyu and Lu, {M. J.} and Wang, {B. W.} and Sun, {H. Y.} and H. Chang",
year = "2006",
month = "10",
doi = "10.1111/j.1365-2362.2006.01718.x",
language = "English",
volume = "36",
pages = "713--719",
journal = "European Journal of Clinical Investigation",
issn = "0014-2972",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure

AU - Shyu, Kou-Gi

AU - Lu, M. J.

AU - Wang, B. W.

AU - Sun, H. Y.

AU - Chang, H.

PY - 2006/10

Y1 - 2006/10

N2 - Background: Mechanical stress increases myocardial myostatin expression. However, the expression of myostatin in chronic heart failure resulting from volume-overload and after treatment with β-blockers is little known. The authors hypothesize that myostatin plays a role in the failing myocardium because of volume-overload. Materials and methods: Aorto-caval shunt was created over a 4-week period in adult Sprague-Dawley rats to induce volume-overload heart failure. Results: Heart weight and body weight ratio significantly increased after shunting. The left ventricular end-diastolic dimension also significantly increased. Treatment with carvedilol in the shunt group reversed the increase in heart weight and ventricular dimension to the baseline values. Myocardial and skeletal myostatin proteins were up-regulated in the shunt group. The mRNA of myocardial myostatin also increased in the shunt group. Treatment with carvedilol reversed both protein and mRNA of myocardial myostatin to the baseline values. Treatment with N-acetylcysteine and doxazosin partially decreased myostatin mRNA and protein expression as compared with the shunt group. Carvedilol normalized the increased immunohistochemical labelling of myocardial myostatin in the shunt group. Conclusion: Myocardial myostatin mRNA and protein expression were up-regulated in the rat model of volume-overload heart failure. Treatment with carvedilol is associated with a limitation of increased myostatin expression in the failing ventricular myocardium.

AB - Background: Mechanical stress increases myocardial myostatin expression. However, the expression of myostatin in chronic heart failure resulting from volume-overload and after treatment with β-blockers is little known. The authors hypothesize that myostatin plays a role in the failing myocardium because of volume-overload. Materials and methods: Aorto-caval shunt was created over a 4-week period in adult Sprague-Dawley rats to induce volume-overload heart failure. Results: Heart weight and body weight ratio significantly increased after shunting. The left ventricular end-diastolic dimension also significantly increased. Treatment with carvedilol in the shunt group reversed the increase in heart weight and ventricular dimension to the baseline values. Myocardial and skeletal myostatin proteins were up-regulated in the shunt group. The mRNA of myocardial myostatin also increased in the shunt group. Treatment with carvedilol reversed both protein and mRNA of myocardial myostatin to the baseline values. Treatment with N-acetylcysteine and doxazosin partially decreased myostatin mRNA and protein expression as compared with the shunt group. Carvedilol normalized the increased immunohistochemical labelling of myocardial myostatin in the shunt group. Conclusion: Myocardial myostatin mRNA and protein expression were up-regulated in the rat model of volume-overload heart failure. Treatment with carvedilol is associated with a limitation of increased myostatin expression in the failing ventricular myocardium.

KW - Beta-blocker

KW - Congestive heart failure

KW - Gene expression

KW - Myostatin

UR - http://www.scopus.com/inward/record.url?scp=33748707456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748707456&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2362.2006.01718.x

DO - 10.1111/j.1365-2362.2006.01718.x

M3 - Article

C2 - 16968467

AN - SCOPUS:33748707456

VL - 36

SP - 713

EP - 719

JO - European Journal of Clinical Investigation

JF - European Journal of Clinical Investigation

SN - 0014-2972

IS - 10

ER -